PER-028-02已完成未知
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Adult patients of any race and either sex with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation component) or ocular hypertension.
排除标准
- •Better corrected visual acuity worse than 0.6 logMar in one eye or the other.
- •History of severe eye disease, chronic or recurrent.
- •History of ocular traumatism during the last six months.
- •History of ocular infection or eye inflammation during the last three months.
研究者
相似试验
进行中（未招募）
不适用
The Efficacy and Safety of Travoprost 0.004% versus Tafluprost 0.005% in Primary Open-Angle Glaucoma or Ocular Hypertensive Patients.primary open-angle glaucomaocular hypertensionpigment dispersion glaucomaEUCTR2008-006718-10-DEAlcon Laboratories, Inc.
已完成
3 期
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)Glaucoma, Open-AngleOcular HypertensionNCT00051142Alcon Research
招募中
不适用
Efficacy IOP lowering and safety of Travoprost Ophthalmic Solution in Normal Tension Glaucoma patients.GlaucomaJPRN-UMIN000007026I.CHANGE study group100
已完成
4 期
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular HypertensionGlaucomaNCT00966940Alcon Research51
招募中
不适用
Assessing the efficacy of changing to Travoprost/Timolol fixed combination, as replacement therapy in patients on prostaglandin monotherapyGlaucomaJPRN-UMIN000007028I.CHANGE study group180